According to today's Daily Mail, veterinary surgeon Lis Crowsley may have been killed as she tried to protect her dogs from cows that were with their newly-born calves.
Click here for the full story.
Figures produced by the Royal College of Veterinary Surgeons show that almost half of the first cohort of newly-qualified vets to sign up to the Professional Development Phase (PDP) have now completed it.
The PDP is a web-based database that enables new graduates to develop, and reflect on, their professional skills during their first year in clinical practice. Completing the PDP became a professional obligation for all newly-qualified vets from 2007 onwards. Of the 636 vets who graduated in 2007, 586 (92%) signed up to PDP and 290 have now completed. Of the 616 vets who graduated in 2008, 546 (88%) have so far registered for the PDP.
Freda Andrews, RCVS Head of Education, said: "Undertaking PDP is a professional requirement for every newly-qualified vet working in clinical practice. The first vets to undertake PDP seem to be taking around 15 months from signing up to signing off. Properly completing PDP counts as the first year's CPD and we strongly recommend that this year's graduates sign up as soon as they have found their first clinical role."
The PDP is also open to any vet returning to practice.
To find out more about PDP requirements, log onto www.rcvs.org.uk/pdp, to enrol, email pdp@rcvs.org.uk.
Petplan has announced the winners of its annual Veterinary Awards.
The awards recognise and celebrate staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Isabella von Mesterhazy, Petplan's Head of Marketing, said: "As the leader in the pet insurance market for over 35 years, we have a rich history of working with veterinary practices across the UK. The Veterinary Awards is a great way to celebrate the fantastic work that goes on helping keep pets healthy and their owners happy."
She added: "This year saw over 11,000 nominations which goes to show the appetite from both staff and clients for celebrating exceptional work. We had an outstanding selection of finalists and I'd like to congratulate all the winners who thoroughly deserve their awards."
The winners for each category are:
VET OF THE YEAR - Laura Pugh, Ashfield House Veterinary Hospital - Long Eaton, NottinghamWhat really stood out was Laura's willingness to go above and beyond the call of duty. As well as Laura's stressful day job she is very involved with the local community. Laura writes an animal column in her local neighbourhood magazine, runs evening talks on a variety of subjects and visits local schools.
VET NURSE OF THE YEAR - Catherine Raw, Broadleys Veterinary Hospital - Stirling, ScotlandCatherine's passion for her role within the practice and her dedication to providing the best service for her clients put her above the other finalists. Catherine is not only committed to her professional role of delivering the highest standard of clinical care for her patients and the best service for her clients, but she also devotes a lot of her own time to animal welfare. Catherine is a fantastic role model for her nurses.
VET SUPPORT STAFF OF THE YEAR - Vivienne Jeffs, Arvonia Animal Hospital - Cheltenham, GloucestershireVivienne's reliability, empathy and selflessness really stood out for the judges. Whether it is knowing the name of a pet owner during telephone conversations, or entertaining toddlers in the waiting area, Vivienne is the type of receptionist vet surgeries dream of. The practice would not be the same without her according to those that nominated her.
VET PRACTICE OF THE YEAR - Bridge Veterinary Surgery - Highbridge, SomersetThe practice's hard work and dedication to their clients really impressed the judges. The practice is open 24 hours a day and the dedication the veterinary, with a small practice of only four staff members, it is a particularly well deserved award.
VET PRACTICE MANAGER OF THE YEAR - Cery Lawson-Tankred, Golden Valley Veterinary Hospital - Nailsea, SomersetCery has worked at Golden Valley for over five years, during which time the practice has seen a large degree of upgrade and reinvigoration. Investments made in new equipment and facilities have meant improved care for an expanding array of animals that come through the surgery doors. It was clear to the judges that Cery is the glue that holds the Golden Valley Veterinary Hospital together.
Idexx Laboratories has announced the addition of pradofloxacin (Veraflox, Bayer Animal Health) to the list of antibiotics that it tests samples sent for culture and sensitivity testing against.
The company says that in the past, only a small percentage of the 350-400 samples it processes every day included a specific request from veterinary surgeons to include sensitivity testing to pradofloxacin. The now-routine testing for pradofloxacin is a positive move toward better clinical outcomes in difficult cases, including specific indications such as wound infections, superficial and deep pyoderma, and in cases with infections resistant to other antibiotics.
Idexx says that as the only next generation fluoroquinolone, pradofloxacin has been shown to be the least likely veterinary fluoroquinolone to select for resistance1, giving vets a lower risk option, when they decide to use an antibiotic from this class.
Matt Jones, Microbiology Manager at Idexx Laboratories said: 'Removing the need to specifically request samples to be tested for sensitivity to pradofloxacin has streamlined the culture and sensitivity testing process for vets and will make it easier for them to adhere to good practice in antibiotic prescription.
"This is important, as antimicrobial resistance is an area of deep international concern. Idexx are pleased to be helping vets identify those cases for which pradofloxacin may be effective and believe that, where indicated, it will lead to improved compliance and excellent clinical outcomes with the added benefit of reducing the likelihood of selecting for resistance, when compared to older generation fluoroquinolones."
The company says this move is in line with BSAVA's PROTECT initiative, which stresses the importance of culture and sensitivity, especially when prescribing antibiotics of the fluoroquinlone class.
Reference
Merial has announced the launch of a new Blippar app designed to educate horse owners about gastric ulcers.
By using the app - which is available free from the App Store for iPhone or Google Play for Android phones - to scan the company's Gastrogard (omeprazole) adverts, posters or website, clients can watch an educational film with one of the UK's leading specialists in equine ulcers, Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine, demonstrating the signs of ulcers and diagnosis via gastroscopy.
Merial's Equine Marketing and Technical Manager Louise Radford MRCVS said: "With 60% of competition horse and 38% of leisure horses & ponies estimated to have gastric ulcers¹,²,³, it's important that horse owners are aware of the signs of this under-diagnosed condition.
"We know that the number of horses diagnosed and treated for ulcers falls significantly short of incidence levels. We hope that this app will help to raise awareness and prompt more horse owners to consult their vet about gastric ulceration."
A separate Blippar app is also available for horse owners that have been prescribed GastroGard. By scanning the pack, clients can view educational video footage on gastric ulcers, find management tips on treatment and prevention, and set a reminder for future risk periods.
For more information, visit: http://www.equinegastriculcers.co.uk, contact your local Merial equine territory specialist or call Merial Customer Support on 0870 6000123.
References
Normally only accessible by ISFM members, the channel has been opened up as a free resource to help vets keep on top of CPD and includes over 40 webinars presented by internationally recognised veterinary specialists.
Topics include: anaesthesia and analgesia, behaviour, emergency and critical care, feline medicine and neurology. Each webinar is worth 1 hour of CPD and you get a certificate.
The channel includes a new webinar: ‘COVID-19 – helping cats cope’ which looks at how you can advise owners to help their cats deal with changes at home.
ISFM’s Feline Medicine Consultant, Sam Taylor said: "ISFM is committed to educating veterinary professionals on all things feline, so we are delighted to be able to bring some of our normally member-only benefits to a wider audience during this challenging time."
To register for the ISFM webinar channel, visit: https://icatcare.org/event/isfm-vet-webinars/
The company says that while attendance CPD events are permitted under UK coronavirus guidelines, it has found that many lecturers and delegates are unwilling or unable to participate in them for the time being.
The main distinction between Zoom and traditional webinars is the ability for members of the audience to see each other and the presenter, which helps engender a sense of community and of a live event. Central CPD says it gives all the feel and interactivity of attending a CPD course in person.
Central CPD is now delivering day-long events split into four sessions, which gives delegates the choice of joining for a whole day or just selected sessions.
The Zoom presentations are recorded in high definition, with the audience removed, so delegates can catch up on anything they missed later via Central CPD On-Demand.
Two days of CPD have so far been delivered via the new livestream service. Lecturer Mike Rhodes BVM&S CertVOphthal DipECVO MRCVS said: "This was my first time giving a livestream CPD day and compared to my previous experience of prerecorded lectures I found the interaction with the delegates very good fun - this could definitely be the new future with regards to veterinary CPD: COVID or no COVID!"
Livestream courses are free for subscribers or £45 + VAT per event, including unlimited access to the recorded footage afterwards.
Upcoming events for December are:
Details and booking information can be found at https://www.centralcpd.com/categories/30
BlueSky says that conventional treatment for equine sarcoids, which are induced by tumour antigens E6 and E7 of the bovine papillomavirus, have only limited effect and typically result in the recurrence of the tumours.
However, research published by the company in PLoSONE1 showed that sarcoids treated with delNS/E6E7 were completely and permanently eliminated.
For the study, 29 horses were treated with different regimes involving direct injection into the tumours over three years.
Visible and very significant regression of the sarcoids was achieved in 20 of the treated horses, and 100% regression of the sarcoids in 10 equine patients.
Thomas Muster, CEO of BlueSky Immunotherapies said: "The complete elimination of very aggressive and difficult-to-cure equine sarcoids is yet another important proof of the potential offered by our delNS platform."
In addition, the systemic delNS-mediated immune stimulation eliminated non-injected sarcoids and the papillomavirus that caused the sarcoids.
Thomas added: "We are therefore confident that we will also be able to successfully heal and/or eliminate the cervical tumours of the women enrolled in the clinical trials currently under way."
The range includes a spray, collars and diffusers.
Unlike many other pheromone diffusers which need to be plugged into a wall socket, Virbac's uses a patent-pending slow release technology which doesn't need power.
Virbac says the new range has been scientifically proven with published studies which demonstrate not only their effectiveness in managing stress-related behaviours in dogs and cats, but also an equivalent and superior efficacy to the current market leading pheromone products 1,2,3
Andrew Connolly, Virbac's Marketing Director for the UK and Ireland said: "Veterinary professionals have a crucial role to play in supporting their clients with the behavioural management of their pets, both when visiting the practice and at home, and the benefits of pheromones in helping to manage dog and cat behaviour are already very well recognised."
"With Zenidog and Zenifel we hope to make pheromone therapy easier, more cost-effective and better for the environment."
Zenidog and Zenifel are available to order from NVS, Covetrus and VSSCo now.
Open to all veterinary professionals looking to enhance their knowledge and skills in emergency and critical care, this year's Congress has a lineup of over 30 internationally-renowned speakers and leading clinicians and offers up to 70 hours of CPD.
This year’s keynote speaker is specialist transplant nurse and chair of the UK One Health Coordination Group, Helen Ballantyne, and organisers will also be welcoming veterinary nurse Ken Yagi, formerly program director of the CPR simulation lab at Cornell University, who’ll deliver an update on the new RECOVER (CPR) guidelines being released this year.
Simon Hagley, ECC Specialist and Clinical Director at Vets Now hospital in Manchester said: “We are confident our 2024 programme offers something for everyone, no matter what stage of your ECC career you are at, from students through to specialists and everything in between.
"We listened to delegate feedback from last year’s event, and we have brought back some firm favourites including our ’Controversies’ and ‘Joined Up Thinking sessions’, but we have introduced exciting new streams including 'Catastrophic case conversations'.
“We’ve also we’ve extended the popular nursing streams from last year to span two entire days and lunchtime case presentations from interns across the country are also on the programme.”
https://www.vets-now.com/congress
Following a nationwide search to find the UK's top veterinary professionals for 2010, Petplan has announced the winners of the Veterinary Awards.
The Petplan Veterinary Awards recognise and applaud staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Alison Andrew, Petplan's Marketing Manager, says she is thrilled by the ongoing success of the awards. "Britain is known to be an animal-loving nation and with millions of households owning cats and dogs, pets play a central part in family life. The Petplan Veterinary Awards give us the opportunity, on behalf of all pet owners across the UK, to thank the veterinary profession for the outstanding service they provide to our pets.
"This is the 11th year of the awards and we received over 1800 nominations, which really highlights the high regard that the profession and pet owners have for these awards."
VET OF THE YEARMike Hewitt, Wendover Heights Veterinary Centre, Buckinghamshire Having worked in the profession for over 20 years Mike is highly respected by clients, valued by colleagues and loved by pets. Having received so many heartfelt customer nominations, Mike's constant professionalism and approachable manner shone through.
VET NURSE OF THE YEARLouise Want, Feldon Veterinary Centre, WarwickshireThe constant support and care Louise provides to both her colleagues and clients really stood out. She is a great inspiration to all and having worked in the veterinary profession for 30 years, Louise is as passionate and dedicated, as when she first started.
VET RECEPTIONIST OF THE YEAR Carol Dawson, Kingsteignton Veterinary Group, Devon Carol's compassionate and professional manner really impressed all the judges. Clients instantly feel at ease because of her caring smile and welcoming attitude, while her colleagues find her a great inspiration.
VET PRACTICE OF THE YEAR Mill House Veterinary Surgery and Hospital, Norfolk Mill House Veterinary Surgery and Hospital provides an incredibly high level of service to their clients, and as a collective are extremely dedicated and welcoming. Taking pride in their work they are known by their clients for being efficient, friendly and helpful.
Genitrix has announced the reformulation of Cerusolve, which cleans and deodorises the external ear canal of cats and dogs.
According to the company, the reformulation has enhanced Cerusolve's exfoliant and keratolyic properties and has given it a new fresh fragrance. Cerusolve ingredients now include:
Cerusolve is presented in a 100 ml bottle with a soft canula for application. It is priced at £5.65.
Genitrix Marketing Director Rob Watkins said: "Cerusolve has proved itself in practice as a gentle but effective ear cleaner in dogs and cats. The reformulation has given us the opportunity to increase the acidity of the product following a recent study which suggested that topical acidifying products could be therapeutically beneficial for cutaneous yeast infections.
"We believe the new ingredients will enhance the product and, to celebrate its arrival, we're offering practices the opportunity to buy five bottles of Cerusolve and get one free."
Further details are available from Genitrix on 01403 786345.
Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.
Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.
Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.
In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.
Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."
The RCVS is advising all practices that it is not currently carrying out a data-gathering exercise and that phone calls prompting the return of a survey, and requesting mobile phone numbers, are not being made on behalf of the College.
The warning comes after several practices have called the College to query 'feedback forms' - supposedly issued in relation to the Practice Standards Scheme or the payment of members' retention fees.
The practices were asked to return forms which they had not received, and also to provide mobile phone numbers, by someone who claimed to work for the 'statutory regulator' or 'the RCVS'. Contact phone numbers left by the caller were either RCVS fax numbers or numbers which looked like RCVS direct dial numbers, but were not.
Lizzie Lockett, Head of Communications, said: "This looks like an exercise to gain mobile phone numbers which is being carried out in the College's name. We are currently investigating who might be making these calls. In the meantime, if a practice receives such a call, it would be helpful if they could take down a name and contact number and let us know."
Ring 020 7202 0725 or email l.lockett@rcvs.org.uk to report any suspicious activity.
The National Office of Animal Health Code of Practice Committee has found MSD Animal Health in breach of the NOAH Code on promotion for its advertisment for Equilis Prequenza.
The advert appeared in three separate issues of Veterinary Times (15, 22 and 29 September 2014), on the rear back cover of the 2014 BEVA Congress proceedings, and on the inside back cover of the 2014 Congress Planner. It contained the phrase “Neuraminidase antibodies provided a degree of protection in the case of HA strain/vaccine mismatch”, when viewed against the context of the advertisement headed ‘Why have part when you can have it all?”.
The Committee’s view was that the item in the context of the advertisement was intended to mean, and did convey, the meaning that the inclusion of NA antigens in an equine vaccine gave that vaccine a clinical advantage over vaccines which did not. This claim was not substantiated. Accordingly, the Committee found the phrase in breach of Code of Practice Clauses 4.1(iii) misleading, 4.1(vi) contained an exaggerated claim, 4.1(vii) implied it had a special merit which was not substantiated, 4.2(i) was not accurate and 4.2(ii) was not based upon an up-to-date evaluation of all the evidence.
Full details of the Committee’s rulings can be found on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
The awards, which which celebrate initiatives that advance the quality of veterinary care and demonstrate a commitment to using an evidence-based approach, will be open for applications until 13th January 2023.
The two new award categories are Antimicrobial Stewardship and Canine Cruciate Outcomes.
The Canine Cruciate Outcome Awards are to recognise and celebrate individuals and teams who are using Quality Improvement initiatives alongside RCVS Knowledge’s Canine Cruciate Registry (CCR) to monitor and improve their canine cruciate surgery outcomes.
Applications are invited by surgeons and teams who are using the CCR.
The Antimicrobial Stewardship Awards, which are divided into farm animal, equine, and companion animal categories, aim to showcase practical examples where individuals and teams are improving responsible antimicrobial prescribing.
In addition, the charity is looking for entries for its existing awards for students and those who have implemented Quality Improvement (QI) techniques.
The Veterinary Evidence Student Awards enables students from around the world to enhance their academic and research skills by writing a Knowledge Summary and submitting it for publication to Veterinary Evidence, RCVS Knowledge's open access, peer-reviewed journal.
The Quality Improvement Awards showcase the implementation of Quality Improvement techniques which drive improvement within the professions.
www.rcvsknowledge.org/awards
The theme for the 2025 conference is how to make veterinary work sustainable, creating teams that can reliably work at their best, feel positive about work, and feel supported and valued by their team.
Keynote speaker, Amanda Oates BA (hons), MSc Strategic HRD, C.C.I.P.D. (pictured) will be talking about the concept of restorative veterinary practice, and how it relies on establishing a restorative workplace culture.
There will be three streams at the conference.
In the first stream, VetLed founder and Training Director, Dan Tipney will be joined by guest speakers to help delegates understand how they can make a difference to the way they work using human factors tools and techniques proven in human medicine and other safety-critical professions.
In the second stream, VetLed’s Community Lead, Hannah Godfrey, will be joined by human behaviour expert Katie Ford to help delegates understand themselves as humans, to acknowledge and accommodate their own needs and the needs of others, and to work better as a team.
The third stream will be hosted by VetLed Managing Director, Cat Auden, and a Chartered Psychologist, Ergonomist, and Human Factors Specialist. In this stream, delegates who are already familiar with human factors concepts will be encouraged to think big, share ideas, and shape the veterinary profession.
Tickets: £190.80
https://www.vetled.co.uk/conference
The existing MSD Animal Health Connect Bursary and Ruminant Research Bursary have been combined into the new MSD Animal Health Research Bursary which is designed to support the future of the veterinary profession through research.
The student arm of the new Research Bursary will award £1,000 to the five best research project applications received from veterinary students across all UK veterinary schools, with an opportunity for an additional £1,000 top prize and £500 runner-up prize.
The veterinary surgeon arm of the Research Bursary will offer three awards, consisting of two ruminant awards and one companion animal award, of up to £4,000 each. The veterinary practitioner proposals will be judged by University academics to ensure independent assessment.
Michelle Townley, Veterinary Advisor at MSD Animal Health said: "Our existing Research Bursaries are well known amongst students and practitioners, having run for over 25 years for the student bursary and 6 years for the ruminant bursary. To increase our support for the veterinary profession through research we have decided to combine our Research Bursaries and add some new categories to help appeal to as wide an audience as possible. This way we can offer a broader level of support for both existing companion animal and ruminant practitioners and our veterinary surgeons of the future. We aim to engage as many people as possible so the MSD Animal Health Research Bursary will be supported by a new website page and social media package to encourage as much interest from students and practitioners as possible."
Student bursary applications are now invited, with a deadline for entries of Friday 26th May 2017. Veterinary practitioners will be invited to apply in September 2017.
For further details go to the MSD Animal Health Research Bursary website at www.msd-animal-health.co.uk/researchbursary.aspx.
Eurovet Animal Health has launched Thyforon Flavoured (levothyroxine sodium, POM-V), which replaces the company's canine hypothyroid treatment Forthyron.
Eurovet says that Thyforon Flavoured has the same clinical efficacy of Forthyron and veterinary surgeons won't need to make any dose adjustments when transitioning to the new product.
However, Thyforon Flavoured, with its palatable formulation, now offers the benefit of being voluntarily accepted by over 70 per cent of dogs in taste trials1. In addition there is a new 800 mcg formulation which gives more prescribing options, particularly for the treatment of large and giant breeds.Thyforon Flavoured comes as easy-break tablets to make dose adjustment straightforward, in an easy-to-dispense blister pack.
Thyforon Flavoured is available now - the person responsible for placing the practice drug order should just ask for Thyforon Flavoured when placing the next drug order and where appropriate, the practice management system should be updated to reflect the new name.
Reference1. Eurovet Animal Health Internal Study report, acceptance study, November 2011
Petplan has launched a new system through which veterinary staff at Appointed Representative (AR) practices can activate 4 weeks Immediate Veterinary Cover (IVC) for clients' puppies, kittens and rabbits at www.petplanvet.co.uk.
Petplan says the new system will greatly improve its service to the veterinary industry, enabling same day information transfer, reducing the amount of paperwork and admin for veterinary staff as well as ruling out the chances of paperwork getting lost or delayed in the post.
Simon Masding, Petplan Head of Sales and Partnerships said: "Petplan has the most established cover note scheme in the market and due to the strength of our brand and the products we offer is able to generate more insured clients for practices than any other provider. Our team of Account Executives visit practices across the UK on a daily basis which means we understand the pressures of day-to-day practice life. Our new online IVC service is just one of the innovative ways we try to make things easier for veterinary staff so they can focus on looking after clients and their pets."
For more information about becoming a Petplan AR practice, and Immediate Veterinary Cover, call Petplan's Vetline on 0800 316 8800.
Any practices that activate IVC online at petplanvet.co.uk before 31st July 2012 will be entered into a prize draw to win an iPad.
Vétoquinol, the makers of Zylkène, is offering the chance for a veterinary professional to receive a bursary towards the Centre of Applied Ethnology (COAPE) Behaviour Diploma, worth £5000.
The company says behavioural training offers a wealth of benefits to veterinary practices and staff, including safer pet handling, improved client loyalty and a more comfortable environment for animals, as well as the opportunity to help increase the clinic's income.
The COAPE Behaviour Diploma is designed to help professionals further their knowledge of behavioural issues and gives them the skills to deal with situations that may arise during the course of their work. It is broken down into 3 one-year-long courses, each costing £5000.
Jodie Foster of Haygate Vets in Telford was the recipient of last year's bursary and has since been voted the VN Times Welfare Nurse of the Year. She said: "I'd been interested in doing this course for some time, so it was amazing to hear that I'd been selected. I have found it challenging at times, but it's also been very rewarding and has really helped to improve my confidence when dealing with behavioural situations at work.
"The course tutors were fantastic and really fuelled my desire to further develop my knowledge of animal behaviour. The course definitely contributed to being awarded the prize from VN Times so I would strongly recommend that anyone with an interest in pet behaviour applies for the bursary."
To apply, complete the application form at www.zylkenepet.co.uk/COAPE by 10 August 2014, explaining why you want to further your knowledge of animal behaviour and what you hope to achieve on completing the course.
MSD Animal Health UK has announced the launch of Bravecto, which it says is the first and only treatment available for fleas and ticks in dogs that is rapidly effective and offers 12-weeks duration of efficacy.
Bravecto (fluralaner) is the first of a new generation of systemically active ectoparasiticides, the isoxazolines, and will only be available on prescription through veterinary practices. The new product will be available in five strengths of pork liver flavoured palatable chew for different size dogs - one chew per weight band - which MSD says are readily accepted from the hand. Jolian Howell, marketing and technical lead at MSD Animal Health UK said: "Bravecto is a truly unique and exciting innovation which will transform the effective treatment of fleas and ticks - providing protection like never before from a single dose. It is the first in a new generation of products that offer a full 12-week protection and will help keep the treatment of fleas and ticks within veterinary practices."
He continued: "Estimates suggest that flea and tick treatments are applied for just 2.8 months per year so just one dose of Bravecto will immediately deliver much improved levels of treatment for dogs in veterinary care, which is good for the animal and good for the vet." MSD Animal Health says it is investing in the launch of Bravecto with a major marketing and practice support package which aims to raise awareness of fleas and ticks and drive pet owner footfall into practices for flea and tick control.
The new product will be available after BSAVA Congress, where MSD will be giving visitors the opportunity to learn more about it.
The recall is for the following batches only:
Petlife is contacting retailers, veterinary surgeons and wholesale dealers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact Dr J M Ballany on +44 1333 720257 or email: johnballany@btinternet.com.
Pat is the head of the Equine Studies Group at Waltham Petcare Science Institute and an internationally renowned authority on equine nutrition from both veterinary and academic perspective.
Her courses, book publications and webinars are aimed at providing practising equine vets with the latest knowledge and essential know-how on equine nutrition, whether for performance horses, leisure animals or the retired family pony.
Earlier this month Pat was one of several speakers at the British Equine Veterinary Association’s CPD course: From superfoods to supplements: How to know more than the owner.
Earlier this year she co-edited and co-authored two chapters of Veterinary Clinics Equine Practice: Nutrition: 1) What would be good for all veterinarians to know about equine nutrition, and 2) Nutritional considerations when dealing with an obese adult equine.
Next month she will chair a panel discussion titled Nutritional Management of the Competitive Equine Athlete for Vets through VetPD.
In the autumn she will be one of several speakers at the Mars Equestrian Equine Veterinary Continuing Education Series focusing on senior, obese and laminitic horses.
For more information, visit: www.spillers-feeds.com
The College says this will pave the way for new diagnostic tests for what could be one of the most common causes of pregnancy loss in mares.
The researchers, led by Dr Mandi de Mestre (pictured right), Reader in Reproductive Immunology and Head of the Equine Pregnancy Laboratory at the RVC, collaborated with seven different veterinary practices to gain access to samples from across the UK and Ireland and found that around 20% of the pregnancies lost were aneuploid, which is when a copy of a whole chromosome is either duplicated or lost (similar to Down's).
Charlotte Shilton, RVC PhD, the student who performed the analysis, applied three different genetic approaches to confirm the results.
Work is now underway to identify the underlying cause of these aneuploid pregnancies, with early data from this study suggesting it is most commonly introduced via the egg or sperm. Until now, chromosomal defects such as aneuploidy have only been reported as a rare condition in young horses with developmental disorders.
The researchers say the study explains why the condition is so rare in horses, with most embryos and foetuses possessing this genetic change dying very early in development, as is also observed in human pregnancy. The study highlights the need to reconsider this genetic condition both in pregnancy loss but also for early developmental disorders.
Dr Mandi de Mestre, Reader in Reproductive Immunology at the RVC, said: “Early pregnancy loss remains a very frustrating condition for clinicians to treat as the underlying cause is unknown in around 80% of cases. These findings will allow researchers to develop new diagnostic tests for pregnancy losses, which would offer hope to thousands of owners of breeding mares that suffer this condition.
“A diagnostic test would allow them to make informed decisions on treatment strategies and to advise on whether they should invest in further attempts to breed their mare benefiting both horses and their breeders alike in the future. I would like to thank both the Thoroughbred Breeders Association and our collaborators at Texas A&M University and the participating veterinary surgeons for their support on this project.